The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis

(2013) Kashif Kalam et al.   EUROPEAN JOURNAL OF CANCER

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

(2013) Mihai Gheorghiade et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

(2013) Xavier Bosch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Regulation of angiotensin-(1–7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure

(2011) Wen-na Zong et al.   ACTA PHARMACOLOGICA SINICA

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI

(2011) Edith Pituskin et al.   BMC CANCER

The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy

(2011) Nazanin Fallah-Rad et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Cardioprotective Role of Probucol Against Anthracycline and Trastuzumab-Mediated Cardiotoxicity

(2011) Jonathan R. Walker et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function

(2010) Asimina Hiona et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Trastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study

(2009) Maya Guglin et al.   JOURNAL OF CARDIAC FAILURE

Utility of Tissue Doppler and Strain Rate Imaging in the Early Detection of Trastuzumab and Anthracycline Mediated Cardiomyopathy

(2009) Davinder S. Jassal et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity

(2009) Mohamed A. Ibrahim et al.   PHARMACOLOGICAL RESEARCH

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

(2008) Deepa Wadhwa et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

(2008) Mohammad Jahanzeb   Clinical Breast Cancer

New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone

(2008) Catherine A. Lemarié et al.   JOURNAL OF MOLECULAR MEDICINE-JMM